Ocumension Therapeutics (1477.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.26B |
| Enterprise Value | 5.04B |
| P/E Ratio | -22.24 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 4.52 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 4.29 |
| Enterprise/EBITDA | -115.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.2 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.04 |
Income Statement
| Revenue | 804.35M |
| Revenue/Share | 1.01 |
| Gross Profit | 360.92M |
| EBITDA | -29.95M |
| Net Income | -158.82M |
| Diluted EPS | -0.2 |
Balance Sheet
| Total Cash | 547.5M |
| Total Cash/Share | 0.69 |
| Total Debt | 187.62M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 3.7 |
| Book Value Per Share | 4.64 |
Price History
| 52-Week Change | -53.31 |
| 52-Week High | 11.08 |
| 52-Week Low | 4.04 |
| Moving Average 50 Days | 5.19 |
| Moving Average 200 Days | 6.85 |
Statistics
| Average Volume | 1.16M |
| Shares Outstanding | 803.92M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
